Navigation Links
Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
Date:5/22/2008

ting effects. Because of its chemical structure, RELISTOR does not affect the opioid-mediated analgesic effects on the CNS.

About Subcutaneous RELISTOR

On April 24, 2008, the United States Food and Drug Administration approved RELISTOR subcutaneous injection for the treatment of OIC in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. The use of RELISTOR beyond four months has not been studied. Wyeth expects to make subcutaneous RELISTOR available in the United States in early June. Subcutaneous RELISTOR has also been approved in Canada and is awaiting Australian approval and European approval, having received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP), the EMEA scientific committee, in April.

Important Safety Information for Subcutaneous RELISTOR

-- RELISTOR is contraindicated in patients with known or suspected

mechanical gastrointestinal obstruction.

-- If severe or persistent diarrhea occurs during treatment, advise

patients to discontinue therapy with RELISTOR and consult their

physician.

-- Use of RELISTOR has not been studied in patients with peritoneal

catheters.

-- The most common adverse reactions with RELISTOR in clinical trials were

abdominal pain, flatulence, and nausea.

RELISTOR Prescribing Information is available at http://www.relistor.com.

About the Collaboration

In December 2005, Wyeth and Progenics Pharmaceuticals entered into an exclusive, worldwide agreement for the joint development and commercialization of methylnaltrexone for the treatment of opioid-induced side effects.

About the Companies

Wyeth Pharmaceuticals, a division of Wyeth, has leading products in the areas of women's health care, infectious disease, gastrointestinal health, central nervous
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
3. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
4. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
5. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
6. Wyeths TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
7. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
8. Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015 Cogentix Medical, Inc. (NASDAQ: CGNT ), ... will release financial results for the first quarter of fiscal ... close on Monday, August 10, 2015. The ... these results on Monday, August 10, 2015 at 4:30 p.m. ... President and Chief Executive Officer, and Brett Reynolds , ...
(Date:7/29/2015)... 29, 2015  Cepheid (Nasdaq: CPHD ) ... to Xpert® Carba-R, with the addition of two ... on-demand, molecular test also detects and differentiates among ... namely KPC, NDM, VIM, IMP-1 and OXA-48. ... or Superbugs, are a growing and expensive challenge ...
(Date:7/29/2015)... and PITTSBURGH , July ... today announced that it received regulatory clearance from the ... for its proposed acquisition of Perrigo Company plc (NYSE: ... Chairman Robert J. Coury commented, "Today marks ... our acquisition of Perrigo and serves as further affirmation ...
Breaking Medicine Technology:Cogentix Medical to Announce First Quarter Fiscal 2016 Results on August 10, 2015 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9
... to Simultaneously Identify Staphylococcus aureus and, Methicillin-Resistant ... DIEGO, Jan. 2 BD Diagnostics, a segment,of ... ), announced today that it,received clearance from the ... GeneOhm(TM) StaphSR assay. This new assay is the ...
... Say, DURHAM, N.C., Dec. 28 Contrary ... not have longer survival, according to,analysis of an ... of "The,Oncologist.", However, the results suggest some ... the possibility that,married patients receive a more aggressive ...
Cached Medicine Technology:BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures 2BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures 3Marital Status Doesn't Affect Lung Cancer Survival 2Marital Status Doesn't Affect Lung Cancer Survival 3
(Date:7/29/2015)... ... July 29, 2015 , ... ... credential for a five-year period, expiring November 30, 2019, during its recent meeting. ... submitting an application demonstrating the program’s compliance with the NCCA’s Standards for the ...
(Date:7/29/2015)... ... July 29, 2015 , ... On July 26th ... by the FDA for nicotine laced liquid products. Their report says cigarette use ... considerably. E-Cigarettes are particularly troublesome to addiction professionals as many of the candy ...
(Date:7/29/2015)... ... 29, 2015 , ... With a new community program in ... Cancer Support Services and announced a new charity campaign to raise funds to ... groups, workshops and educational programs at no charge. Scott Campbell Agency initiates ...
(Date:7/29/2015)... ... July 29, 2015 , ... For the second year ... featured in the list of the 50 fastest growing companies in Jacksonville. This annual ... business community. On July 16th, a team of Vast Bridges staffers were on hand ...
(Date:7/29/2015)... ... ... We are privileged to announce that U.S. News & World Report has ranked ... in the nation for 2015-2016. This marks the 21st consecutive year that the USC Eye ... an honor to be included in the top 10 ophthalmology hospitals by U.S. News & ...
Breaking Medicine News(10 mins):Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3
... Comprehensive Reform, End to Employer,Insurance System, ... future U.S. economic growth. Today,s employer-based system ... insurance system driven by,cost-conscious consumer choice. Those ... Care for All: Moving Beyond the Employer-Based,Health-Insurance ...
... (FDA) has approved DORIBAX(TM),(doripenem for injection) as ... urinary tract infections, including,pyelonephritis. DORIBAX has demonstrated ... Gram-negative bacteria - including Pseudomonas -- that,cause ... CDC, in the U.S., nearly 2 million ...
... teenagers aged 12-18 claim to have been victims of some ... by the University of Haifa and Ben Gurion University. The ... boys and 76% of the girls reported said that they ... Rachel Lev-Wiesel from the University of Haifa,s School of Social ...
... Winners Announced at Annual ASRM Meeting, ... won Ferring,Pharmaceuticals, national 2007 My Little Miracle ... the births of their ,little miracles,children born ... fertility treatments.,The fourth annual contest celebrated the ...
... - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today announced ... Drug,Administration (FDA),s Formal Dispute Resolution process, appealing the,Agency,s ... received a second Approvable Letter from the FDA ... this year. The Company,firmly believes it has met ...
... Hills, NY (Oct. 15, 2007) -- Experts called on ... reverse one of the most serious public health policy ... United States. Neil Blumberg, M.D. and Joanna M. ... the University of Rochester Medical Center, urged that universal ...
Cached Medicine News:Health News:Quality, Affordable Health Care for All 2Health News:Quality, Affordable Health Care for All 3Health News:Quality, Affordable Health Care for All 4Health News:Quality, Affordable Health Care for All 5Health News:MultiVu Video Feed: FDA Approves DORIBAX(TM) (doripenem for injection) for the Treatment of Complicated Intra-abdominal and Complicated Urinary Tract Infections 2Health News:Almost 90 percent of children reported experiencing sexual violence 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 2Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 3Health News:Ferring Announces $10,000 Grand Prize Winner of 2007 My Little Miracle Essay Contest 4Health News:Labopharm appeals FDA's decision on once-daily tramadol 2Health News:Leukocyte reduction seen as significant advance in transfusion medicine 2Health News:Leukocyte reduction seen as significant advance in transfusion medicine 3
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... Equally Spaced, Expandable, Multichannel Pipettor ... and instantly boosts productivity with an industry ... simple adjustment of a slide rod. This ... of liquids between vessels with different configurations. ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... The total ergonomic solution and best ... Soft, feather touch action and ultra lightweight ... Stress-free tip ejection with long, lever tip ... identification , Accepts universal tips or for ...
Medicine Products: